Glimefide M 1 FT Tablet

By Glimefide M

Rx

10 Tablet in a Strip

Composition icon

Composition

Glimepiride(1mg) + Metformin(1000mg)

Manufacturer - Fidelity Lifesciences Pvt Ltd icon

Manufacturer - Fidelity Lifesciences Pvt Ltd

3rd Floor, Suvidha House, Plot No. 2, Shipra Society, Vithal Mandir Road, Above Andhra Bank, Karvenagar, Pune 411052

Expires on or after icon

Expires on or after

March, 2027

About Glimefide M 1 FT Tablet

Glimefide M 1 FT Tablet is classified as an anti-diabetic medication that is commonly prescribed for the treatment of type 2 diabetes in adults. It is a combination of two medicines that work together to help regulate blood sugar levels in individuals with diabetes. It is essential to take Glimefide M 1 FT Tablet with meals and at the same time each day to ensure optimal results. Your doctor will determine the appropriate dosage for you, which may be adjusted periodically based on your blood sugar levels.

It is crucial to continue taking Glimefide M 1 FT Tablet as directed by your doctor, even if you are feeling well or your blood sugar levels are under control. Abruptly stopping the medication without medical advice could lead to a rise in blood sugar levels, posing risks such as kidney damage, vision impairment, nerve issues, and even limb amputation. Remember that medication is only one component of a comprehensive treatment plan that should also involve a healthy diet, regular physical activity, and weight management, as advised by your healthcare provider. Lifestyle choices play a significant role in managing diabetes effectively.

The most commonly reported side effect of Glimefide M 1 FT Tablet is hypoglycemia, characterized by symptoms like sweating, dizziness, headaches, and tremors. It is crucial to be able to recognize these signs and know how to address them promptly. To mitigate the risk of low blood sugar levels, it is recommended to have regular meals and carry a quick source of glucose such as sugary snacks or fruit juice. Consumption of alcohol can further elevate the risk of hypoglycemia and should be avoided. Additional side effects that may occur with this medication include changes in taste, nausea, diarrhea, abdominal discomfort, headaches, and upper respiratory infections. Weight gain may also be experienced by some individuals.

Glimefide M 1 FT Tablet is not suitable for individuals with type 1 diabetes, diabetic ketoacidosis, severe kidney or liver conditions, or a history of heart disease. Pregnant or breastfeeding women should consult their doctor before starting this medication. Regular monitoring of blood sugar levels is essential, and your doctor may recommend periodic blood tests to assess your blood cell counts and liver function. It is crucial to adhere to your doctor's guidance and actively participate in managing your diabetes to achieve optimal health outcomes.


Benefits

Glimefide M 1 FT Tablet offers multiple benefits in the treatment of Type 2 diabetes mellitus. This combination medicine works by increasing the production of insulin in the pancreas, which in turn helps to lower blood glucose levels. Managing blood glucose levels is crucial for individuals with diabetes as it can reduce the risk of serious complications such as kidney damage, eye damage, nerve problems, and limb loss. By regularly taking Glimefide M 1 FT Tablet along with a proper diet and exercise regimen, individuals can lead a normal and healthy life. The tablet contains Glimepiride and Metformin, with Glimepiride stimulating insulin-producing cells in the pancreas to remove sugar from the blood, and Metformin acting as a prolonged-release formulation that reduces sugar production by liver cells, delays sugar absorption from the intestines, and increases muscle cells' sensitivity to insulin for effective sugar removal from the blood. Overall, Glimefide M 1 FT Tablet offers a comprehensive approach to managing Type 2 diabetes mellitus and supporting overall well-being.


How to use the Glimefide M 1 FT Tablet

To use Glimefide M 1 FT Tablet, follow the dosage and duration recommended by your doctor. Swallow the tablet whole with a glass of water, and make sure to take it with food. Do not chew, crush, or break the tablet. Your physician will determine the appropriate dosage and duration based on factors such as your age, weight, and medical condition. It's important not to discontinue taking Glimefide M 1 FT Tablet without consulting your doctor. Remember to take each dose as prescribed, and if you have any questions or concerns about how to use this medication, be sure to discuss them with your healthcare provider.


Uses of Glimefide M 1 FT Tablet

Glimefide M 1 FT Tablet is primarily used in the treatment of Type 2 diabetes mellitus. It is specifically designed to help manage this condition in cases where conventional methods like diet and exercise, along with using a single agent, have not been effective in controlling blood sugar levels. By providing a combination of medications in one convenient tablet, Glimefide M 1 FT Tablet helps in achieving adequate glycemic control for individuals struggling with Type 2 diabetes mellitus.


What conditions Glimefide M 1 FT Tablet treats?

Glimefide M 1 FT Tablet is used for the treatment of type 2 diabetes. This chronic condition affects the body's ability to properly use insulin. Individuals with type 2 diabetes may not produce enough insulin or have a resistance to its action. Common symptoms include increased thirst, frequent urination, slow wound healing, increased hunger, fatigue, and blurred vision. Type 2 diabetes can lead to various complications such as nerve problems, kidney issues, eye problems, loss of limbs, and an increased risk of heart attack or stroke.


Should you consult a doctor?

If you experience type 1 diabetes mellitus, diabetic ketoacidosis, or uncontrolled diabetes with symptoms like nausea, vomiting, rapid weight loss, diarrhea, lactic acidosis, or ketoacidosis, it is important to avoid using Glimefide M 1 FT Tablet. Dehydration, severe infections affecting organs like the lungs or kidneys, and glucose-6-phosphate dehydrogenase (G6PD) deficiency are also conditions where seeking a doctor's advice before taking this medication is crucial. Additionally, if you are recovering from injury, surgery, infections with fever, or stress, or if you have factors that increase the risk of low blood sugar levels (such as undernourishment, irregular meal times, missed meals, diet changes, or hormone-induced disorders), consulting a healthcare professional before starting this medication is recommended. It's important to prioritize your health and safety by discussing these concerns with your doctor before using Glimefide M 1 FT Tablet.


Side effects of Glimefide M 1 FT Tablet

When taking Glimefide M 1 FT Tablet, some common side effects you may experience include headaches, hypoglycemia (low blood sugar), nausea, diarrhea, and stomach pain. These side effects are usually mild and temporary as your body adjusts to the medication. If these side effects persist or if you have concerns about them, it is important to consult your doctor for guidance.


In addition to the common side effects mentioned, other potential side effects of Glimefide M 1 FT Tablet may include taste disturbances, vomiting, metallic taste, loss of appetite, and decreased vitamin B12 levels. It is essential to be aware of signs indicating more serious side effects, such as low blood sugar levels, reduced red blood cell count, platelet count, or white blood cell count, skin rashes, and itching. If you experience any of these severe side effects, stop taking the medication immediately and seek medical attention.


Certain rare but serious side effects that may occur with Glimefide M 1 FT Tablet include lactic acidosis, liver inflammation leading to jaundice, and severe allergic reactions like skin rash, hives, and increased sensitivity to the sun. It is crucial to be vigilant for signs of severe low blood sugar levels that could result in loss of consciousness or seizures. If you notice any of these severe side effects, it is imperative to contact your doctor promptly for further evaluation and management.


Safety advice

scroll

liver

It is important to exercise caution when using Glimefide M 1 FT Tablet in patients with liver disease. Your doctor may need to adjust the dosage accordingly. Typically, this medication is initiated at a low dose for individuals with mild to moderate liver disease. However, it is not advisable to use Glimefide M 1 FT Tablet in patients with severe liver disease. If you have a history of liver diseases or conditions, it is crucial to take Glimefide M 1 FT Tablet with care, and your doctor may modify the dosage as necessary.

scroll

kidney

When using Glimefide M 1 FT Tablet, caution is advised in patients with kidney disease. Dose adjustment may be necessary, and it is not recommended for those with severe kidney disease. Regular monitoring of kidney function is recommended during treatment. If you have a history of kidney issues, consult your doctor for proper guidance before using this medication.

scroll

alcohol

It is unsafe to consume alcohol with Glimefide M 1 FT Tablet, as it may increase the risk of lactic acidosis. Avoid alcohol consumption while taking this medication.

scroll

driving

Do not drive if you experience low or high blood sugar symptoms. Take caution as Glimefide M 1 FT Tablet can reduce alertness. Only drive when fully alert after taking the medication.

scroll

pregnancy

Glimefide M 1 FT Tablet is not recommended for use during pregnancy as it may pose risks to the developing baby. Limited human studies and animal studies have shown potential harm. It is important to consult your doctor before using this tablet if you are pregnant or planning for pregnancy.

scroll

breastfeeding

Glimefide M 1 FT Tablet is not safe to use while breastfeeding as it could be harmful to the baby. Avoid breastfeeding when taking this medication to prevent any potential adverse effects on your baby. Kindly consult your doctor before using this tablet if you are breastfeeding.


Age above 75(Geriatrics)

Glimefide M 1 FT Tablet is not recommended for use in elderly patients (aged 75 years or above) and it should be used with caution in elderly patients (aged 65 years or above), especially in patients with impaired kidney function. Your doctor may assess your kidney function more frequently during treatment with Glimefide M 1 FT Tablet . Consult your doctor before taking Glimefide M 1 FT Tablet.


Age below 6 months(Pediatrics)

Glimefide M 1 FT Tablet is generally not recommended for use in children and adolescents (under 18 years of age). Consult child’s doctor for advice.


Consumption warning before consuming Glimefide M 1 FT Tablet

Before consuming Glimefide M 1 FT Tablet, it is important to note several precautions. Inform your doctor if you have allergies to this medication or any others. This tablet is not suitable for children. Avoid breastfeeding while taking Glimefide M 1 FT Tablet as it may pass into breast milk. Pregnant or planning pregnancy individuals should consult their doctor, as it can harm the unborn baby. It is advised to refrain from consuming alcohol while on this medication, as it can lead to lactic acidosis. Only drive if fully alert. Opt for short, frequent meals and avoid prolonged fasting. Be vigilant for signs of hypoglycemia, such as sweating, dizziness, palpitations, intense thirst, and more. Keep candies, glucose biscuits, or honey/sugar handy and seek medical advice if symptoms occur. Remember to carry these supplies, especially during long trips.


What if you forgot to take Glimefide M 1 FT Tablet?

If you forget to take a dose of Glimefide M 1 FT Tablet, try to take it as soon as you remember. But, if it's close to the time for your next scheduled dose, just skip the missed one and continue with your usual dosing routine. Avoid taking a double dose to make up for the one you missed. It's important to stick to your prescribed dosage schedule for the best results.


What happens if you take overdose of Glimefide M 1 FT Tablet?

In the case of an overdose of Glimefide M 1 FT Tablet, it is critical to seek immediate medical attention. Overdosing on this medication can lead to serious complications, such as a risk of low blood sugar levels and potentially life-threatening lactic acidosis. Symptoms of lactic acidosis that may indicate an overdose include vomiting, abdominal pain accompanied by muscle cramps, a general sense of unwellness with severe fatigue, decreased body temperature, slow heart rate, and difficulty breathing. It is crucial to contact a doctor or visit the nearest hospital if you suspect an overdose to receive prompt and appropriate medical care.


Related lab tests

The 'Glimefide M 1 FT Tablet' is a medication commonly used to treat certain medical conditions. For monitoring the effects of this medication, it is important to track specific lab test results. Some related lab tests that may be necessary while taking Glimefide M 1 FT Tablet include:


1. Glucose - Fasting Blood: This test measures the level of glucose in your blood after fasting for a certain period of time. It helps assess how well your body is managing blood sugar levels.


2. Glucose - Postprandial Blood: This test measures the level of glucose in your blood after consuming a meal. It helps determine how your body responds to food and how well it processes glucose.


3. Glycosylated Hemoglobin: This test, also known as an HbA1c test, provides an average of your blood sugar levels over the past 2-3 months. It is used to monitor long-term blood sugar control and assess the effectiveness of diabetes management.


These lab tests are important for monitoring glucose levels and overall health while taking Glimefide M 1 FT Tablet. Regular monitoring of these tests can help healthcare providers adjust treatment plans as needed to ensure optimal outcomes.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassANTI DIABETIC
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

65

Inclusive of all taxes

Content verified by

chevron-right

Dr. Preeti Kumar

MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology

Last update on 01-Oct-2024